𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate

✍ Scribed by Jan V. Bokhman; Oleg F. Chepick; Alina T. Volkova; Alexander S. Vishnevsky

Book ID
119052023
Publisher
Elsevier Science
Year
1981
Tongue
English
Weight
496 KB
Volume
11
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The risk of venous thromboembolic diseas
The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma : A systematic review
✍ Steven R. Deitcher; Marcelo P. V. Gomes πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 1 views

## Background: Tamoxifen therapy for patients with breast carcinoma is perceived as an independent risk factor for venous thromboembolic events (vte), but the risk associated with other adjuvant therapies is less well recognized. ## Methods: The authors conducted a computerized pubmed literature